ByHeart Recalls Infant Formula Amid Botulism Outbreak Investigation

ByHeart, an organic infant formula manufacturer, has initiated a nationwide recall of all its products in response to a botulism outbreak that has hospitalized 15 infants across 12 states since August.

The Centers for Disease Control and Prevention (CDC) confirmed that one opened can of ByHeart formula contained Clostridium botulinum, the bacterium responsible for producing the botulinum toxin. However, no unopened cans have tested positive, and investigations are ongoing to determine the contamination source.

Infant botulism is a rare but serious condition that affects the nervous system, leading to symptoms such as muscle weakness, poor feeding, and respiratory difficulties. All affected infants, aged between two weeks and five months, have been hospitalized and treated with BabyBIG, the only treatment for infantile botulism in children under one.

ByHeart's recall includes all Whole Nutrition Infant Formula cans and Anywhere Pack pouches. The company is cooperating with health officials, conducting third-party tests on all batches, and allowing full regulatory access to its facilities in Iowa and Oregon. Parents are advised to stop using and dispose of affected products immediately.

The Food and Drug Administration (FDA) noted that while ByHeart accounts for approximately 1% of the U.S. formula market, its products were involved in 40% of botulism cases linked to formula use. Despite the recall, a national infant formula shortage is not anticipated due to ByHeart's small market share.

ByHeart's president, Mia Funt, stated, "We express our deepest sympathy to the families currently impacted by the cases of infant botulism. We are working with the FDA and independent experts to implement the recall quickly while the factual investigation continues."

Health officials continue to investigate the outbreak, and parents are urged to monitor infants for symptoms and seek immediate medical care if concerns arise.